| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124001 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 06/09/2005 | US20050123849 Electrophotographic organophotoreceptors with novel charge transport materials |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | DE10353094A1 Verfahren zur Herstellung linearer organischer Thiophen-Phenylen-Oligomere A process for preparing linear organic thiophene-phenylene oligomers |
| 06/09/2005 | DE10352139A1 Organometallic transition metal compound used for catalyst system for polymerization of olefin, is new |
| 06/09/2005 | DE10351842A1 m-Diaminobenzole und deren Säureaddukte sowie deren Verwendung in Färbemitteln m-diaminobenzenes and their acid adducts, and their use in colorants |
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/09/2005 | CA2545023A1 Novel salicylic anilides |
| 06/09/2005 | CA2544522A1 Vitamin d receptor modulators |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/08/2005 | EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 06/08/2005 | EP1537076A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1392673B1 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
| 06/08/2005 | EP1299774A4 Perfluoroalkylsulfonic acid compounds for photoresists |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | CN1623995A Substituted five member ring heteocyclic compound, bacterial composition containing them and preparation method thereof |
| 06/08/2005 | CN1623988A Biaryl sulfonamides and methods for using same |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205215C Oxime derivatives and the use thereof as latent acids |
| 06/08/2005 | CN1205204C 3-hydroxymethylbenzo [b] thiphene derivatives and process for their preparation |
| 06/08/2005 | CN1205203C Synthesis method of medicine for curing senile dementia |
| 06/08/2005 | CN1205202C N-carbanilides used as pesticides |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/02/2005 | WO2005049023A1 Glyt1 transporter inhibitors |
| 06/02/2005 | WO2005028419A3 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives |
| 06/02/2005 | US20050119495 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 06/02/2005 | US20050119481 Novel amidine derivatives and the use of the same in pharmaceuticals |
| 06/02/2005 | US20050119345 2-Amino-3-alkoxy-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; effective for treating and preventing psychiatric disorders such as schizophrenia, anxiety, bipolar disorder and epilepsy, neurological diseases such as drug dependence, Alzheimer's disease, Huntington's chorea |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119257 Cyclic sulfone containing retroviral protease inhibitors |
| 06/02/2005 | US20050119245 Alpha -, beta -, and gamma -amino acid derivatives, e.g., S)-2-{N'-[4-(4-Fluoro-phenoxy)-phenyl]-N''-cyano-guanidino}-3-phenyl-N-(3-pyrrolidin-1-yl-propyl)-propionamide for the treatment of central nervous system conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/01/2005 | EP1535942A1 Process for producing dendrimer, building block compound, and process for producing thiophene compound |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1535629A1 Drugs for improving the prognosis of brain injury and a method of screening the same |
| 06/01/2005 | EP1534716A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 06/01/2005 | EP1534700A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534664A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 06/01/2005 | EP1534661A1 Spirobifluorene derivatives, their preparation and uses thereof |
| 06/01/2005 | EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1534276A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1534259A2 Sulfonamides as potassium channel blockers |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1222159B1 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/26/2005 | WO2005047421A1 Organic element for electroluminescent devices |
| 05/26/2005 | WO2005047282A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | WO2005047232A1 Novel oxy-nitriles |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046599A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 05/26/2005 | US20050113596 Nitrating a 2-(2-formylphenoxy) or 2-(2-formylphenylsulfido) alkyl ester or alkoic acid in the presence of sulfuric acid |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113442 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/26/2005 | US20050113338 Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 05/26/2005 | CA2545617A1 Novel oxy-nitriles |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532135A1 Nf-kb inhibitors |
| 05/25/2005 | EP1532134A1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 05/25/2005 | EP1532133A1 Nf-:b inhibitors |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532105A1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 05/25/2005 | EP1532101A1 Method for the production of monoalkylamino ketones |
| 05/25/2005 | EP1532100A1 Method for the enantioselective hydrogenation of amino alcohols |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |